Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 12, Number 6—June 2006

Dispatch

Mixed Cryptosporidium Infections and HIV

Vitaliano Cama*†, Robert H. Gilman†‡, Aldo Vivar§, Eduardo Ticona¶, Ynes Ortega#, Caryn Bern*, and Lihua Xiao*Comments to Author 
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Johns Hopkins University, Baltimore, Maryland, USA; ‡Asociación Benéfica Proyectos en Informática, Salud, Medicina y Agricultura, Lima, Peru; §Hospital Arzobispo Loayza, Lima, Peru; ¶Hospital Dos de Mayo, Lima, Peru; #University of Georgia, Griffin, Georgia, USA

Main Article

Figure

Multilocus polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) analysis of specimens previously identified as Cryptosporidium canis and C. felis. A) Agarose gel electrophoresis of PCR-amplified products of specimens previously identified as C. canis (lanes 1–3) and C. felis (lanes 4 and 5) with molecular tools based on the small subunit (SSU) rRNA, dihydrofolate reductase (DHFR), and Cryptosporidium oocyst wall protein (COWP). Molecular markers in all photos are 100-bp

Figure. Multilocus polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) analysis of specimens previously identified as Cryptosporidium canis and C. felis. A) Agarose gel electrophoresis of PCR-amplified products of specimens previously identified as C. canis (lanes 1–3) and C. felis (lanes 4 and 5) with molecular tools based on the small subunit (SSU) rRNA, dihydrofolate reductase (DHFR), and Cryptosporidium oocyst wall protein (COWP). Molecular markers in all photos are 100-bp ladders. B) RFLP analysis of DHFR-based PCR amplification products using BpuA I restriction enzyme; lanes 1, 4, and 5 are C. hominis; lane 2 is C. parvum; and lane 3 is C. meleagridis. C) RFLP analysis of COWP-based PCR amplification products using Rsa I restriction enzyme; lanes 1, 4, and 5 are C. hominis; lane 2 is C. parvum; and lane 3 is C. meleagridis. D) RFLP analysis of the SSU-based PCR products using restriction enzymes Ssp I (left) and Vsp I (right); the combined patterns for lanes 1 to 3 correspond to C. canis and lanes 4 and 5 to C. felis.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

World Malaria Day - April 25, 2014 - Invest in the future, defeat malaria

20th Anniversary - National Infant Immunization Week - Immunization. Power to Protect.

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO